|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 39230 |
FusionGeneSummary for TPM2_TPM3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TPM2_TPM3 | Fusion gene ID: 39230 | Hgene | Tgene | Gene symbol | TPM2 | TPM3 | Gene ID | 7169 | 7170 |
| Gene name | tropomyosin 2 | tropomyosin 3 | |
| Synonyms | AMCD1|DA1|DA2B|HEL-S-273|NEM4|TMSB | CAPM1|CFTD|HEL-189|HEL-S-82p|NEM1|OK/SW-cl.5|TM-5|TM3|TM30|TM30nm|TM5|TPM3nu|TPMsk3|TRK|hscp30 | |
| Cytomap | 9p13.3 | 1q21.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | tropomyosin beta chainepididymis secretory protein Li 273nemaline myopathy type 4tropomyosin 2 (beta) | tropomyosin alpha-3 chainalpha-tropomyosin, slow skeletalcytoskeletal tropomyosin TM30epididymis luminal protein 189epididymis secretory sperm binding protein Li 82pheat-stable cytoskeletal protein 30 kDatropomyosin 3 nutropomyosin gammatropomyosi | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P07951 | P06753 | |
| Ensembl transtripts involved in fusion gene | ENST00000378300, ENST00000378292, ENST00000329305, ENST00000360958, | ENST00000368533, ENST00000469717, ENST00000330188, ENST00000341485, ENST00000341372, ENST00000328159, ENST00000271850, ENST00000302206, ENST00000368531, ENST00000323144, ENST00000368530, | |
| Fusion gene scores | * DoF score | 10 X 10 X 2=200 | 7 X 6 X 4=168 |
| # samples | 10 | 9 | |
| ** MAII score | log2(10/200*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/168*10)=-0.900464326449086 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: TPM2 [Title/Abstract] AND TPM3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | TPM2 | GO:0043462 | regulation of ATPase activity | 17194691 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | F00784 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000378300 | ENST00000368533 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000469717 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000330188 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000341485 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000341372 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000328159 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000271850 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000302206 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000368531 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000323144 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378300 | ENST00000368530 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-3CDS | ENST00000378292 | ENST00000368533 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000469717 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000330188 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000341485 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000341372 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000328159 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000271850 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000302206 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000368531 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000323144 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000378292 | ENST00000368530 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-3CDS | ENST00000329305 | ENST00000368533 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000469717 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000330188 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000341485 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000341372 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000328159 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000271850 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000302206 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000368531 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000323144 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000329305 | ENST00000368530 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-3CDS | ENST00000360958 | ENST00000368533 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000469717 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000330188 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000341485 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000341372 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000328159 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000271850 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000302206 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000368531 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000323144 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
| intron-5UTR | ENST00000360958 | ENST00000368530 | TPM2 | chr9 | 35685682 | - | TPM3 | chr1 | 154145590 | - |
Top |
FusionProtFeatures for TPM2_TPM3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| TPM2 | TPM3 |
| Binds to actin filaments in muscle and non-muscle cells.Plays a central role, in association with the troponin complex, inthe calcium dependent regulation of vertebrate striated musclecontraction. Smooth muscle contraction is regulated by interactionwith caldesmon. In non-muscle cells is implicated in stabilizingcytoskeleton actin filaments. The non-muscle isoform may have arole in agonist-mediated receptor internalization.{ECO:0000250|UniProtKB:P58774, ECO:0000250|UniProtKB:P58775}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TPM2_TPM3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TPM2_TPM3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TPM2_TPM3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TPM2_TPM3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | TPM2 | C1836447 | Nemaline myopathy 4 | 4 | CTD_human;ORPHANET;UNIPROT |
| Hgene | TPM2 | C0220662 | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 3 | CTD_human;ORPHANET;UNIPROT |
| Hgene | TPM2 | C1834523 | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 2 | CTD_human;ORPHANET;UNIPROT |
| Hgene | TPM2 | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
| Tgene | TPM3 | C1836448 | Nemaline myopathy 1 | 9 | CTD_human;ORPHANET;UNIPROT |
| Tgene | TPM3 | C0546264 | Congenital Fiber Type Disproportion | 5 | ORPHANET;UNIPROT |
| Tgene | TPM3 | C0024667 | Animal Mammary Neoplasms | 2 | CTD_human |
| Tgene | TPM3 | C0024668 | Mammary Neoplasms, Experimental | 2 | CTD_human |
| Tgene | TPM3 | C0001418 | Adenocarcinoma | 1 | CTD_human |
| Tgene | TPM3 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
| Tgene | TPM3 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | TPM3 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Tgene | TPM3 | C0040136 | Thyroid Neoplasm | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|